Consequently, GATA-3 expression in these PTCL, beyond possibly informing disease ontology, has emerged as a potential biomarker for this genetically high-risk subset of PTCL, NOS [18]. Here, GATA3 is linked to mature T-cell and NK-cell non-Hodgkin lymphoma.